Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,725 | -23,964 | -14,836 | -10,457 | 6,645 |
| Depreciation Amortization | 11 | 12 | 9 | N/A | N/A |
| Accounts payable and accrued liabilities | -946 | 1,447 | -788 | -866 | 556 |
| Other Working Capital | -3,476 | 1,776 | -278 | -2,225 | 1,318 |
| Other Operating Activity | 16,580 | -318 | 2,343 | 4,748 | -9,554 |
| Operating Cash Flow | $-14,556 | $-21,048 | $-13,549 | $-8,800 | $-1,035 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | N/A | -37 | N/A | N/A |
| Other Investing Activity | -14,750 | 0 | -500 | -250 | 0 |
| Investing Cash Flow | $-14,757 | $0 | $-537 | $-250 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 149 |
| Common Stock Issued | 109,294 | N/A | N/A | 53,411 | N/A |
| Other Financing Activity | 0 | 0 | -102 | 4,983 | 1,000 |
| Financing Cash Flow | $109,294 | $0 | $-102 | $58,394 | $1,149 |
| Beginning Cash Position | 14,450 | 35,497 | 49,686 | 341 | 227 |
| End Cash Position | 94,430 | 14,450 | 35,497 | 49,686 | 341 |
| Net Cash Flow | $79,980 | $-21,048 | $-14,188 | $49,345 | $114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,556 | -21,048 | -13,549 | -8,800 | -1,035 |
| Capital Expenditure | -7 | 0 | -37 | N/A | N/A |
| Free Cash Flow | -14,564 | -21,048 | -13,586 | -8,800 | -1,035 |